PMC:7402624 / 42592-43085
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 446 | 385-387 | Disease | denotes | HD | MESH:D006816 |
| 447 | 416-424 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1505 | 248-252 | Chemical | denotes | UMAP | |
| 1507 | 212-221 | Disease | denotes | mortality | MESH:D003643 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T321 | 55-57 | Disease | denotes | BH | http://purl.obolibrary.org/obo/MONDO_0010873 |
| T322 | 385-387 | Disease | denotes | HD | http://purl.obolibrary.org/obo/MONDO_0007739 |
| T323 | 407-409 | Disease | denotes | RD | http://purl.obolibrary.org/obo/MONDO_0009973 |
| T324 | 416-424 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T708 | 45-49 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
| T709 | 407-409 | http://purl.obolibrary.org/obo/CLO_0008770 | denotes | RD |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T295 | 178-183 | Chemical | denotes | donor | http://purl.obolibrary.org/obo/CHEBI_17891 |
| T296 | 378-383 | Chemical | denotes | donor | http://purl.obolibrary.org/obo/CHEBI_17891 |
| T297 | 385-387 | Chemical | denotes | HD | http://purl.obolibrary.org/obo/CHEBI_73925 |
| T298 | 400-405 | Chemical | denotes | donor | http://purl.obolibrary.org/obo/CHEBI_17891 |
| T299 | 407-409 | Chemical | denotes | RD | http://purl.obolibrary.org/obo/CHEBI_73812 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T247 | 0-493 | Sentence | denotes | Significance determined by unpaired Wilcoxon test with BH correction: *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. (C) Heatmap of indicated immune parameters by row; donor type, disease severity, and mortality indicated across top. (D) UMAP projection of aggregated flow cytometry data. (E) Transformed UMAP projection; density contours drawn separately for healthy donor (HD), recovered donor (RD), and COVID-19 subjects (see Methods). (F) Bars represent mean of UMAP Component 1. |